Weiss H J, Lages B
Department of Medicine, St Luke's-Roosevelt Hospital Center, New York, NY 10019.
Blood. 1988 Mar;71(3):629-35.
The activation of platelets and the coagulation mechanism was studied by collecting blood from a standard bleeding time incision at 30-second intervals and measuring the plasma concentrations of fibrinopeptide A (FPA), platelet factor 4 (PF4), and thromboxane B2 (TxB2). FPA was observed in the first samples (30 to 60 seconds) obtained, increased progressively until cessation of bleeding, and was markedly diminished after heparin administration, thus indicating that thrombin formation occurs early in incisional blood. PF4 increased monotonically throughout blood sampling, whereas the major increase in TxB2 appeared near the cessation of bleeding. The initial increase in FPA content occurred normally in patients with deficiencies of either factor IX or VIII, was markedly diminished in patients with factor X or V deficiency, and was delayed in patients with factor VII deficiency. These studies suggest that tissue factor activation of the classic (activation of factor X) extrinsic coagulation mechanism occurs as an early event during the arrest of bleeding from bleeding time incisions. The relation of the aforementioned to platelet activation is less clear because there was no consistent correlation between decreased FPA formation and impaired PF4 secretion or TxB2 production. In fact, the latter were normal in some subjects with the most impaired FPA formation, which suggests that both collagen and thrombin, perhaps synergistically, may contribute to platelet activation during the primary arrest of bleeding.
通过在标准出血时间切口处每隔30秒采集血液,并测量血浆中纤维蛋白肽A(FPA)、血小板因子4(PF4)和血栓素B2(TxB2)的浓度,研究血小板激活和凝血机制。在最初采集的样本(30至60秒)中观察到FPA,其在出血停止前逐渐增加,在给予肝素后显著减少,这表明凝血酶形成在切口出血早期发生。在整个采血过程中PF4单调增加,而TxB2的主要增加出现在出血接近停止时。FPA含量的最初增加在IX因子或VIII因子缺乏的患者中正常发生,在X因子或V因子缺乏的患者中显著减少,在VII因子缺乏的患者中延迟出现。这些研究表明,经典的(X因子激活)外源性凝血机制的组织因子激活在出血时间切口止血过程中是一个早期事件。上述情况与血小板激活的关系尚不清楚,因为FPA形成减少与PF4分泌受损或TxB2产生之间没有一致的相关性。事实上,在一些FPA形成受损最严重的受试者中,后者是正常的,这表明胶原蛋白和凝血酶可能协同作用,在出血初期止血过程中促进血小板激活。